NEUTRA CORP.
A financially distressed OTC entity reporting significant net losses, deep retained earnings deficits, and total liabilities exceeding total assets with negligible recent revenue.
A financially distressed OTC entity reporting significant net losses, deep retained earnings deficits, and total liabilities exceeding total assets with negligible recent revenue.
An investor might consider NTRR only for a speculative turnaround play if management can successfully restructure debt and revive dormant operations within the next fiscal cycle. The low market cap associated with OTC distressed stocks offers high theoretical upside potential if the company avoids liquidation and announces a successful capital raise or merger. Investors seeking exposure to deep value opportunities may view the current negative equity as a pricing error that could correct upon any positive operational news."
Investors should strictly avoid NTRR due to the immediate risk of insolvency given that liabilities exceed assets by nearly $740,000 and cash reserves are virtually non-existent. The company has posted consecutive years of significant losses with zero revenue in 2023, indicating a failed business model with no clear path to profitability. High interest expenses and lack of operating cash flow suggest the firm is burning through remaining resources without generating returns for shareholders."
NEUTRA CORP. (NTRR) is a financially distressed entity operating in niche markets with negligible revenue generation and significant accumulated losses. The company reports substantial liabilities exceeding its total assets, resulting in a negative shareholders' equity of approximately $774,000. Despite minimal operational activity indicated by low revenue and cash flow figures, the firm maintains a distinct corporate structure on the OTC market.
Management has struggled to stabilize operations as evidenced by a net loss of $-561,417 and negative operating cash flow of -$153,243. The company's balance sheet is fundamentally compromised with current liabilities significantly outpacing current assets and shareholders' equity remaining deeply negative. While financing activities provided temporary liquidity, the core business model appears non-viable given the lack of revenue generation and persistent losses.
The OTC market hosts numerous small-cap and distressed entities that often struggle with liquidity and regulatory scrutiny compared to major exchanges. Companies in this space frequently face challenges related to maintaining compliance while navigating severe financial distress or business model failures. Industry dynamics are characterized by high volatility, frequent delistings, and a reliance on speculative investor interest rather than fundamental earnings power."
| Metric | 2023 |
|---|---|
| Revenue | $68.0K |
| Cost of Revenue | $32.7K |
| Gross Profit | $35.3K |
| Operating Expenses | $333.0K |
| Operating Income | $-297.7K |
| G&A | $228.0K |
| D&A | $78.9K |
| Depreciation | $78.9K |
| Other OpEx | $105.0K |
| Non-Operating Income | $-260.2K |
| Interest Expense | $62.1K |
| Pre-Tax Income | $-557.9K |
| Income Tax | $3.5K |
| Continuing Ops | $-561.4K |
| Discontinued Ops | $0 |
| Net Income | $-561.4K |
| Minority Interest | $0 |
| Net to Common | $-561.4K |
| Metric | 2023 |
|---|---|
| Current Assets | $25.8K |
| Cash & Equivalents | $2.0K |
| Inventory | $23.8K |
| Other Current Assets | $0 |
| Long-Term Assets | $49.4K |
| PP&E (Net) | $49.4K |
| Other LT Assets | $0 |
| Total Assets | $75.2K |
| Current Liabilities | $759.6K |
| Accounts Payable | $233.1K |
| Other Current Liab | $524.5K |
| Long-Term Liabilities | $54.2K |
| Total Liabilities | $813.8K |
| Shareholders' Equity | $-773.8K |
| Retained Earnings | $-11.5M |
| Total L&E | $75.2K |
| Metric | 2023 |
|---|---|
| Net Income (CFO) | $-561.4K |
| Non-Cash Adjustments | $232.6K |
| Working Capital Changes | $175.6K |
| Cash from Operations | $-153.2K |
| Cash from Investing | $0 |
| Cash from Financing | $154.2K |
| FX Effect | $0 |
| Net Change in Cash | $913 |
| Beginning Cash | $1.1K |
| Ending Cash | $2.0K |
Core Operations: The company generates minimal revenue from its primary activities, reflected in low cost of revenue and gross profit figures relative to operating expenses. Other Activities: Significant non-operating losses and other income/loss items suggest sporadic or discontinued business lines contributing to overall volatility. Financing Activities: The company relies heavily on external financing, evidenced by a positive cash flow from financing against negative operating cash flows.
Insolvency Risk: Total liabilities of $813,795 far exceed total assets of $75,175, creating a high probability of default or forced liquidation in the near term. Accumulated Deficits: A retained earnings deficit of $-11.5M indicates long-term unprofitability and an inability to self-fund operations without continuous external capital injection. Revenue Instability: The company recorded zero revenue in 2023, signaling a complete halt or severe contraction in primary business activities which threatens survival. Liquidity Constraints: Ending cash reserves of only $1,969 are insufficient to cover current liabilities of $759,639, indicating an immediate inability to meet short-term obligations.
Niche Market Presence: Despite financial distress, the company maintains an active listing and legal entity status allowing for future restructuring opportunities. Cost Structure: With minimal current assets and inventory, the firm operates with a lean balance sheet that limits immediate liquidity risks but also constrains growth. Regulatory Compliance: As a publicly traded entity on the OTC market, NEUTRA CORP. adheres to reporting standards, providing transparency even during periods of financial instability.
Not financial advice. All content is for informational purposes only. Data may contain errors. Consult a qualified financial advisor before making investment decisions.